AF
NVRO

Amalgamated Financial’s NEVRO CORP. NVRO Stock Holding History

Amalgamated Financial’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$410K Buy
+5,665
New +$408K ﹤0.01% 1606

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Amalgamated Financial's NVRO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in NEVRO CORP. (NVRO) in Q1 2022: 5,665 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #1606 among its holdings.

195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

  • Amalgamated Financial held 5,665 shares of NEVRO CORP. worth $410K as of Q1 2022.
  • NEVRO CORP. was a new Amalgamated Financial position in Q1 2022.
  • NEVRO CORP. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1606 holding.
  • 195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.